Pediatric oncology: current views and outcomes (Q35064122)

6 August 2017

1 reference

title

Pediatric oncology: current views and outcomes (English)

1 reference

6 August 2017

Gregory H Reaman

1

1 reference

6 August 2017

publication date

1 December 2002

1 reference

Pediatric Clinics of North America

6 August 2017

published in

1 reference

6 August 2017

volume

49

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

1305-18, vii

1 reference

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Molecular biology of neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherap

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Chemotherapy for high-grade gliomas of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

CHROMOSOME DELETION IN A CASE OF RETINOBLASTOMA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Molecular epidemiology: on the path to prevention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to studies of human cancer causation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

The multistep nature of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Exploiting genetic alterations to design novel therapies for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

The evaluation of adenoviral p53-mediated bystander effect in gene therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Conditionally replicating herpes vectors for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Triple helix formation and the antigene strategy for sequence-specific control of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Antigen recognition by class I-restricted T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Genetic control of programmed cell death in the nematode C. elegans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Apoptosis in cancer therapy: crossing the threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Mechanisms of p53-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Death receptors: signaling and modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Perforin-dependent nuclear targeting of granzymes: A central role in the nuclear events of granule-exocytosis-mediated apoptosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Pathways of apoptosis and the modulation of cell death in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Regulation of cell death protease caspase-9 by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Developmental therapeutics in childhood cancer. A perspective from the Children's Oncology Group and the US Food and Drug Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

Oncogenic role of "master" transcription factors in human leukemias and sarcomas: a developmental model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Retinoblastoma and long arm delection of chromosome 13. Attempts to define the deleted segment

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2802%2900102-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(02)00102-5

1 reference

release_o3izwwqezbdyzllea4dsk4t32y

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/o3izwwqezbdyzllea4dsk4t32y

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference